ATE118348T1 - Liposome hoher stabilität und verfahren zur herstellung und verwendung. - Google Patents

Liposome hoher stabilität und verfahren zur herstellung und verwendung.

Info

Publication number
ATE118348T1
ATE118348T1 AT89903532T AT89903532T ATE118348T1 AT E118348 T1 ATE118348 T1 AT E118348T1 AT 89903532 T AT89903532 T AT 89903532T AT 89903532 T AT89903532 T AT 89903532T AT E118348 T1 ATE118348 T1 AT E118348T1
Authority
AT
Austria
Prior art keywords
production
high stability
liposomes
liposome
stability liposomes
Prior art date
Application number
AT89903532T
Other languages
English (en)
Inventor
Alan L Weiner
Leonard F Estis
Andrew S Janoff
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22437880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE118348(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE118348T1 publication Critical patent/ATE118348T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89903532T 1987-12-04 1988-11-30 Liposome hoher stabilität und verfahren zur herstellung und verwendung. ATE118348T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12897487A 1987-12-04 1987-12-04

Publications (1)

Publication Number Publication Date
ATE118348T1 true ATE118348T1 (de) 1995-03-15

Family

ID=22437880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89903532T ATE118348T1 (de) 1987-12-04 1988-11-30 Liposome hoher stabilität und verfahren zur herstellung und verwendung.

Country Status (5)

Country Link
EP (1) EP0389570B2 (de)
JP (1) JP2817883B2 (de)
AT (1) ATE118348T1 (de)
DE (1) DE3853079T3 (de)
WO (1) WO1989005151A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437577A1 (de) * 1989-08-01 1991-07-24 The University Of Michigan Topische verabreichung von in dehydratisierungs-/rehydratisierungsliposomen eingeschlossenen peptiden/proteinen
US5783179A (en) * 1991-08-09 1998-07-21 Syntex (U.S.A.) Inc. C-reactive protein fragment with immunomodulatory activity
AU2583892A (en) * 1991-09-11 1993-04-05 Pitman-Moore, Inc. Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides
KR940011013A (ko) * 1992-11-27 1994-06-20 최근선 서방성 소마트로핀 제제의 제조방법
US10596115B2 (en) * 2013-07-17 2020-03-24 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) † 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4603044A (en) * 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
EP0172007B1 (de) * 1984-08-10 1991-05-22 Syntex (U.S.A.) Inc. Stabile Liposome mit wasserlöslichen Arzneimitteln
JPS6176414A (ja) * 1984-09-21 1986-04-18 Shionogi & Co Ltd リポソーム製剤の製法
DE3576117D1 (de) * 1984-09-24 1990-04-05 Michael Mezei Mehrphasige pharmazeutische zusammensetzung.
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
ATE78158T1 (de) * 1985-05-22 1992-08-15 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
US4722842A (en) * 1985-10-11 1988-02-02 President And Fellows Of Harvard College Growth inhibitory factor
JPS6295134A (ja) * 1985-10-21 1987-05-01 Nippon Saafuakutanto Kogyo Kk リポソ−ムの製造法
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
JPH01501228A (ja) * 1986-09-18 1989-04-27 リポソーム　テクノロジー，インコーポレイテッド 高濃度リポソーム処理方法
US4743583A (en) * 1987-07-20 1988-05-10 Temple University Sustained release protein compositions and method for making

Also Published As

Publication number Publication date
JPH03502924A (ja) 1991-07-04
DE3853079T3 (de) 2000-11-09
EP0389570A1 (de) 1990-10-03
EP0389570B2 (de) 2000-07-19
EP0389570A4 (en) 1991-01-09
EP0389570B1 (de) 1995-02-15
WO1989005151A1 (en) 1989-06-15
DE3853079T2 (de) 1995-06-14
DE3853079D1 (de) 1995-03-23
JP2817883B2 (ja) 1998-10-30

Similar Documents

Publication Publication Date Title
DE3879218D1 (de) Medizinisches instrument und verfahren zur herstellung.
DE68922726D1 (de) Medizinisches material und verfahren zur herstellung.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
DE3888177T2 (de) Schnellauflösbare arzneimitteldosierungseinheit sowie verfahren zur herstellung.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
DE68910969D1 (de) Verfahren und vorrichtung zur herstellung von lipidbläschen.
DE68908030T2 (de) Katheter und Methoden zur Herstellung.
DE3485198D1 (de) Verfahren zur herstellung optisch aktiver aryloxypropionsaeuren und deren derivate.
ATA92888A (de) Verfahren zur herstellung hochstabiler weichgelatinekapseln fuer therapeutische zwecke
DE3784518T3 (de) Medizinisches material und verfahren zur herstellung.
ATE118348T1 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
DE3885304D1 (de) Zubereitung für zahnbehandlung und verfahren zur herstellung.
AT359197B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
DE3881665T2 (de) Pregnanabkömmlinge und verfahren zur herstellung.
AT388293B (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
DE3854780D1 (de) Nukleosid-derivate und verfahren zur herstellung
DE3850601D1 (de) Verfahren zur Herstellung von Phospholipidderivate.
AT366574B (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung
DE3854157D1 (de) Medizinisches material und verfahren zur herstellung.
DE68910689D1 (de) Hygienische matratze und verfahren zur herstellung.
ATA240088A (de) Verfahren zur herstellung von diphenylessigsaeuredimethylamid
ATA47688A (de) Piperazin-derivate und verfahren zur herstellung derselben
ATA250986A (de) Verfahren zur herstellung neuer, optisch aktiver tert.butylester der weinsaeure und einiger o,o-diacylderivate
ATA238087A (de) Verfahren zur herstellung von pharmazeutischen loesungen von oxazaphosphorinen mit verbesserter stabilitaet

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee